
DOI . ORG {
}
Title[redir]:
Inhibition of Nuclear Factor-κB Enhances the Antitumor Effect of Paclitaxel Against Gastric Cancer with Peritoneal Dissemination in Mice | Digestive Diseases and Sciences
Description:
Intraperitoneal (i.p.) administration of paclitaxel is useful for treating malignant tumors with peritoneal dissemination, but the therapeutic efficacy is limited. Chemoresistance due to paclitaxel-induced nuclear factor-kappa B (NF-κB) activation is an important cause of suboptimal therapeutic efficacy. The purpose of this study was to prove that addition of nafamostat mesilate (FUT-175), a synthetic serine protease inhibitor and an NF-κB inhibitor, to i.p. paclitaxel enhances antitumor effects of paclitaxel against gastric cancer with peritoneal dissemination. In vitro, we assessed NF-κB activity and apoptosis in response to treatment with FUT-175 alone, paclitaxel alone, or a combination of FUT-175 and paclitaxel in a human gastric cancer cell line (MKN-45). In vivo, we established peritoneal dissemination in nude mice by i.p. injection of MKN-45 cells. The animals received i.p. injections of FUT-175 alone three times a week (FUT-175 group), of paclitaxel alone once a week (paclitaxel group), or a combination of FUT-175 and paclitaxel (combination group) three times and once a week, respectively. In the combination group, paclitaxel-induced NF-κB activation was inhibited and apoptosis was enhanced in comparison with those in the other groups both in vitro and in vivo. In the combination group, number and weight of peritoneal nodules were significantly lower than those in the paclitaxel group (p = 0.0009 and p = 0.0417, respectively). In the survival analysis, the combination group had a significantly better survival than the paclitaxel group (p = 0.0048). FUT-175 enhances the antitumor effect of i.p. paclitaxel against gastric cancer with peritoneal dissemination by inhibiting NF-κB activation in mice.
Matching Content Categories {📚}
- Education
- Science
- Social Networks
Content Management System {📝}
What CMS is doi.org built with?
Custom-built
No common CMS systems were detected on Doi.org, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of doi.org audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Doi.org Make Money? {💸}
We don't see any clear sign of profit-making.
Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Doi.org could be secretly minting cash, but we can't detect the process.
Keywords {🔍}
google, scholar, pubmed, article, cas, cancer, paclitaxel, gastric, nuclear, peritoneal, nfkappab, cell, fut, res, combination, human, pancreatic, inhibition, dissemination, intraperitoneal, activation, nafamostat, mesilate, group, carcinoma, antitumor, mice, inhibitor, apoptosis, cells, factor, enhances, uwagawa, access, chemotherapy, clin, privacy, cookies, content, haruki, fujiwara, furukawa, paclitaxelinduced, nfκb, study, vitro, resistance, taxol, oncol, factorkappab,
Topics {✒️}
paclitaxel-induced nuclear factor-kappa month download article/chapter inhibiting nf-κb activation paclitaxel-induced nf-κb activation nuclear factor-κb enhances tnf-alpha-induced apoptosis nuclear factor-kappab p65 ryota iwase & toya ohashi assessed nf-κb activity article digestive diseases gemcitabine-induced cell death constitutively active nf-kappab nuclear factor kappa nuclear factor-kappa nuclear factor-kappab nuclear factor kappab full article pdf enhanced anti-tumor therapy nf-kappab activation privacy choices/manage cookies cell growth regulation nf-κb inhibitor mediated cell death nf-kappab complexes nf-kappab antiapoptosis paclitaxel-induced apoptosis human breast cancer reveals cell cycle advanced gastric carcinoma pathological complete response breast cancer cells systemic combined chemotherapy intraperitoneal paclitaxel combined intraperitoneal antineoplastic agents suppress caspase-8 activation synthetic protease inhibitor taxol-induced polymerization inhibits lung metastasis taxol-induced apoptosis advanced gastric cancer anti-tumor effect established peritoneal dissemination check access instant access advanced pancreatic cancer rela transcription factor european economic area treating malignant tumors suboptimal therapeutic efficacy ikappabalpha super-repressor
Schema {🗺️}
WebPage:
mainEntity:
headline:Inhibition of Nuclear Factor-κB Enhances the Antitumor Effect of Paclitaxel Against Gastric Cancer with Peritoneal Dissemination in Mice
description:Intraperitoneal (i.p.) administration of paclitaxel is useful for treating malignant tumors with peritoneal dissemination, but the therapeutic efficacy is limited. Chemoresistance due to paclitaxel-induced nuclear factor-kappa B (NF-κB) activation is an important cause of suboptimal therapeutic efficacy. The purpose of this study was to prove that addition of nafamostat mesilate (FUT-175), a synthetic serine protease inhibitor and an NF-κB inhibitor, to i.p. paclitaxel enhances antitumor effects of paclitaxel against gastric cancer with peritoneal dissemination. In vitro, we assessed NF-κB activity and apoptosis in response to treatment with FUT-175 alone, paclitaxel alone, or a combination of FUT-175 and paclitaxel in a human gastric cancer cell line (MKN-45). In vivo, we established peritoneal dissemination in nude mice by i.p. injection of MKN-45 cells. The animals received i.p. injections of FUT-175 alone three times a week (FUT-175 group), of paclitaxel alone once a week (paclitaxel group), or a combination of FUT-175 and paclitaxel (combination group) three times and once a week, respectively. In the combination group, paclitaxel-induced NF-κB activation was inhibited and apoptosis was enhanced in comparison with those in the other groups both in vitro and in vivo. In the combination group, number and weight of peritoneal nodules were significantly lower than those in the paclitaxel group (p = 0.0009 and p = 0.0417, respectively). In the survival analysis, the combination group had a significantly better survival than the paclitaxel group (p = 0.0048). FUT-175 enhances the antitumor effect of i.p. paclitaxel against gastric cancer with peritoneal dissemination by inhibiting NF-κB activation in mice.
datePublished:2012-07-18T00:00:00Z
dateModified:2012-07-18T00:00:00Z
pageStart:123
pageEnd:131
sameAs:https://doi.org/10.1007/s10620-012-2311-4
keywords:
Nafamostat mesilate
Paclitaxel
Gastric cancer
Peritoneal dissemination
Intraperitoneal chemotherapy
Gastroenterology
Hepatology
Oncology
Transplant Surgery
Biochemistry
general
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig6_HTML.jpg
isPartOf:
name:Digestive Diseases and Sciences
issn:
1573-2568
0163-2116
volumeNumber:58
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Koichiro Haruki
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Hiroaki Shiba
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuki Fujiwara
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Kenei Furukawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Ryota Iwase
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Tadashi Uwagawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Takeyuki Misawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Toya Ohashi
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Katsuhiko Yanaga
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Inhibition of Nuclear Factor-κB Enhances the Antitumor Effect of Paclitaxel Against Gastric Cancer with Peritoneal Dissemination in Mice
description:Intraperitoneal (i.p.) administration of paclitaxel is useful for treating malignant tumors with peritoneal dissemination, but the therapeutic efficacy is limited. Chemoresistance due to paclitaxel-induced nuclear factor-kappa B (NF-κB) activation is an important cause of suboptimal therapeutic efficacy. The purpose of this study was to prove that addition of nafamostat mesilate (FUT-175), a synthetic serine protease inhibitor and an NF-κB inhibitor, to i.p. paclitaxel enhances antitumor effects of paclitaxel against gastric cancer with peritoneal dissemination. In vitro, we assessed NF-κB activity and apoptosis in response to treatment with FUT-175 alone, paclitaxel alone, or a combination of FUT-175 and paclitaxel in a human gastric cancer cell line (MKN-45). In vivo, we established peritoneal dissemination in nude mice by i.p. injection of MKN-45 cells. The animals received i.p. injections of FUT-175 alone three times a week (FUT-175 group), of paclitaxel alone once a week (paclitaxel group), or a combination of FUT-175 and paclitaxel (combination group) three times and once a week, respectively. In the combination group, paclitaxel-induced NF-κB activation was inhibited and apoptosis was enhanced in comparison with those in the other groups both in vitro and in vivo. In the combination group, number and weight of peritoneal nodules were significantly lower than those in the paclitaxel group (p = 0.0009 and p = 0.0417, respectively). In the survival analysis, the combination group had a significantly better survival than the paclitaxel group (p = 0.0048). FUT-175 enhances the antitumor effect of i.p. paclitaxel against gastric cancer with peritoneal dissemination by inhibiting NF-κB activation in mice.
datePublished:2012-07-18T00:00:00Z
dateModified:2012-07-18T00:00:00Z
pageStart:123
pageEnd:131
sameAs:https://doi.org/10.1007/s10620-012-2311-4
keywords:
Nafamostat mesilate
Paclitaxel
Gastric cancer
Peritoneal dissemination
Intraperitoneal chemotherapy
Gastroenterology
Hepatology
Oncology
Transplant Surgery
Biochemistry
general
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-012-2311-4/MediaObjects/10620_2012_2311_Fig6_HTML.jpg
isPartOf:
name:Digestive Diseases and Sciences
issn:
1573-2568
0163-2116
volumeNumber:58
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Koichiro Haruki
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Hiroaki Shiba
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuki Fujiwara
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Kenei Furukawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Ryota Iwase
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Tadashi Uwagawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Takeyuki Misawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Toya Ohashi
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Katsuhiko Yanaga
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Digestive Diseases and Sciences
issn:
1573-2568
0163-2116
volumeNumber:58
Organization:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Koichiro Haruki
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
email:[email protected]
name:Hiroaki Shiba
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Yuki Fujiwara
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Kenei Furukawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Ryota Iwase
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Tadashi Uwagawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Takeyuki Misawa
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Toya Ohashi
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Katsuhiko Yanaga
affiliation:
name:The Jikei University School of Medicine
address:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
name:Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(234)
- Explore the financials of https://link.springer.com/privacystatement
- Get to know https://link.springer.com/article/10.1007/s10620-012-2311-4/#main's earnings
- What are the total earnings of https://link.springer.com?
- What's https://idp.springer.com/auth/personal/springernature?redirect_uri=https://link.springer.com/article/10.1007/s10620-012-2311-4's gross income?
- How much money does https://link.springer.com/article/10.1007/s10620-012-2311-4/#eds-c-header-nav generate?
- What's https://link.springer.com/journals/'s gross income?
- How much does https://www.springernature.com/gp/authors net monthly?
- What's the income of https://link.springernature.com/home/?
- Discover the revenue of https://link.springer.com/article/10.1007/s10620-012-2311-4/#eds-c-header-popup-search
- How profitable is https://order.springer.com/public/cart?
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/ bring in each month?
- Earnings of https://link.springer.com/article/10.1007/s10620-012-2311-4/journal/10620
- Profit of https://link.springer.com/article/10.1007/s10620-012-2311-4/#citeas
- How profitable is https://link.springer.com/article/10.1007/s10620-012-2311-4/journal/10620/aims-and-scope?
- How much does https://submission.springernature.com/new-submission/10620/3 make?
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/#auth-Koichiro-Haruki-Aff1-Aff2 pull in?
- What's the financial intake of https://link.springer.com/article/10.1007/s10620-012-2311-4/#Aff1?
- Learn how profitable https://link.springer.com/article/10.1007/s10620-012-2311-4/#Aff2 is on a monthly basis
- How much cash flow does https://link.springer.com/article/10.1007/s10620-012-2311-4/#auth-Hiroaki-Shiba-Aff1 have monthly?
- Check the income stats for https://link.springer.com/article/10.1007/s10620-012-2311-4/#auth-Yuki-Fujiwara-Aff1-Aff2
- What is the earnings of https://link.springer.com/article/10.1007/s10620-012-2311-4/#auth-Kenei-Furukawa-Aff1?
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/#auth-Ryota-Iwase-Aff1-Aff2 bring in each month?
- How much revenue does https://link.springer.com/article/10.1007/s10620-012-2311-4/#auth-Tadashi-Uwagawa-Aff1 produce monthly?
- Get to know what's the income of https://link.springer.com/article/10.1007/s10620-012-2311-4/#auth-Takeyuki-Misawa-Aff1
- https://link.springer.com/article/10.1007/s10620-012-2311-4/#auth-Toya-Ohashi-Aff2 income
- Revenue of https://link.springer.com/article/10.1007/s10620-012-2311-4/#auth-Katsuhiko-Yanaga-Aff1
- What's the monthly money flow for https://link.springer.com/article/10.1007/s10620-012-2311-4/article/10.1007/s10620-012-2311-4/metrics?
- How much money does https://wayf.springernature.com?redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs10620-012-2311-4 generate?
- How much does https://link.springer.com/product/springer-plus gross monthly?
- What's the revenue for https://www.springernature.com/gp/librarians/licensing/agc/journals?
- Learn about the earnings of https://link.springer.com/10.1186/s40792-020-00818-9?fromPaywallRec=true
- https://link.springer.com/10.1038/s41598-024-82218-9?fromPaywallRec=true's total income per month
- What are the total earnings of https://link.springer.com/10.1007/s10120-019-00971-7?fromPaywallRec=true?
- How much income does https://link.springer.com/article/10.1007/s10620-012-2311-4/subjects/chemoprevention have?
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/subjects/chemotherapy make?
- Discover the revenue of https://link.springer.com/article/10.1007/s10620-012-2311-4/subjects/mechanism-of-action
- How much income is https://link.springer.com/article/10.1007/s10620-012-2311-4/subjects/nf-kappab earning monthly?
- Profit of https://link.springer.com/article/10.1007/s10620-012-2311-4/subjects/nkt-cells
- What are the earnings of https://link.springer.com/article/10.1007/s10620-012-2311-4/subjects/tumour-necrosis-factor?
- How much does http://scholar.google.com/scholar_lookup?&title=SEER%20cancer%20statistics%20review%2C%201975%E2%80%932000&publication_year=2003&author=Ries%2CL&author=Eisner%2CM&author=Kosary%2CC pull in monthly?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10026754
- Monthly income for https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:STN:280:DyaK1M7ltVyitA%3D%3D
- How much income is http://scholar.google.com/scholar_lookup?&title=Expression%20of%20vascular%20endothelial%20growth%20factor%20correlates%20with%20hematogenous%20recurrence%20in%20gastric%20carcinoma&journal=Surgery&doi=10.1016%2FS0039-6060%2899%2970265-5&volume=125&pages=195-201&publication_year=1999&author=Saito%2CH&author=Tsujitani%2CS&author=Kondo%2CA earning monthly?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9689986?
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:STN:280:DyaK1czlsVCnsg%3D%3D pull in?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Phase%20II%20study%20of%20Taxol%20in%20patients%20with%20advanced%20gastric%20carcinoma&journal=Cancer%20J%20Sci%20Am&volume=4&pages=269-274&publication_year=1998&author=Ajani%2CJA&author=Fairweather%2CJ&author=Dumas%2CP
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7915154?
- What's the income generated by https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:STN:280:DyaK2czkvVWktg%3D%3D each month?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Update%20on%20the%20antitumor%20activity%20of%20pacitaxel%20in%20clinical%20trials&journal=Ann%20Pharmacother&volume=28&pages=S18-S22&publication_year=1994&author=Rowinsky%2CEK?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17633066 earn?
- Monthly income for https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:STN:280:DC%2BD2svhsVWjsg%3D%3D
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Cytoreduction%20and%20intraperitoneal%20chemotherapy%20for%20carcinomatosis%20from%20gastric%20cancer&journal=Cancer%20Treat%20Res&volume=134&pages=357-373&publication_year=2007&author=Yonemura%2CY&author=Bando%2CE&author=Kawamura%2CT produce monthly?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19605503
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:STN:280:DC%2BD1Mfisl2isQ%3D%3D gross monthly?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Phase%20II%20study%20of%20weekly%20intravenous%20and%20intraperitoneal%20paclitaxel%20combined%20with%20S-1%20for%20advanced%20gastric%20cancer%20with%20peritoneal%20metastasis&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdp260&volume=21&pages=67-70&publication_year=2010&author=Ishigami%2CH&author=Kitayama%2CJ&author=Kaisaki%2CS?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16394300's financial summary
- Income figures for https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BD28XhvV2qsQ%3D%3D
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Intraperitoneal%20cisplatin%20and%20paclitaxel%20in%20ovarian%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa052985&volume=354&pages=34-43&publication_year=2006&author=Armstrong%2CDK&author=Bundy%2CB&author=Wenzel%2CL
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10962577?
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BD3cXmsVKlsLk%3D bring in each month?
- How much does http://scholar.google.com/scholar_lookup?&title=Paclitaxel%20sensitivity%20of%20breast%20cancer%20cells%20with%20constitutively%20active%20NF-kappaB%20is%20enhanced%20by%20IkappaBalpha%20super-repressor%20and%20parthenolide&journal=Oncogene&doi=10.1038%2Fsj.onc.1203768&volume=19&pages=4159-4169&publication_year=2000&author=Patel%2CNM&author=Nozaki%2CS&author=Shortle%2CNH generate monthly?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12226754 bring in?
- What are the total earnings of https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BD38XmvVOqsbk%3D?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=The%20function%20of%20multiple%20IkappaB%3A%20NF-kappaB%20complexes%20in%20the%20resistance%20of%20cancer%20cells%20to%20Taxol-induced%20apoptosis&journal=Oncogene&doi=10.1038%2Fsj.onc.1205848&volume=21&pages=6510-6519&publication_year=2002&author=Dong%2CQG&author=Sclabas%2CGM&author=Fujioka%2CS?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11485895
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BD3MXms1WisLs%3D make?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=New%20insights%20into%20the%20role%20of%20nuclear%20factor-kappaB%20in%20cell%20growth%20regulation&journal=Am%20J%20Pathol&doi=10.1016%2FS0002-9440%2810%2961708-7&volume=159&pages=387-397&publication_year=2001&author=Chen%2CF&author=Castranova%2CV&author=Shi%2CX each month?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8864118 make?
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DyaK28XmsFOhu70%3D bring in each month?
- What's the income of http://scholar.google.com/scholar_lookup?&title=An%20essential%20role%20for%20NF-kappaB%20in%20preventing%20TNF-alpha-induced%20cell%20death&journal=Science&doi=10.1126%2Fscience.274.5288.782&volume=274&pages=782-784&publication_year=1996&author=Beg%2CAA&author=Baltimore%2CD?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8864120?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Suppression%20of%20TNF-alpha-induced%20apoptosis%20by%20NF-kappaB&journal=Science&doi=10.1126%2Fscience.274.5288.787&volume=274&pages=787-789&publication_year=1996&author=Antwerp%2CDJ&author=Martin%2CSJ&author=Kafri%2CT earns monthly
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11875461 rake in every month?
- How profitable is https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BD38XitVWlt7g%3D?
- How much money does http://scholar.google.com/scholar_lookup?&title=NF-kappaB%20at%20the%20crossroads%20of%20life%20and%20death&journal=Nat%20Immunol&doi=10.1038%2Fni0302-221&volume=3&pages=221-227&publication_year=2002&author=Karin%2CM&author=Lin%2CA generate?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11751513?
- What is the earnings of https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BD38XltFShtg%3D%3D?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Nuclear%20factor-kappaB%20p65%20%28RelA%29%20transcription%20factor%20is%20constitutively%20activated%20in%20human%20gastric%20carcinoma%20tissue&journal=Clin%20Cancer%20Res&volume=7&pages=4136-4142&publication_year=2001&author=Sasaki%2CN&author=Morisaki%2CT&author=Hashizume%2CK
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15154625's total income per month
- What's http://scholar.google.com/scholar_lookup?&title=Nuclear%20factor-kappaB%20p65%20is%20a%20prognostic%20indicator%20in%20gastric%20carcinoma&journal=Anticancer%20Res&volume=24&pages=1071-1075&publication_year=2004&author=Yamanaka%2CN&author=Sasaki%2CN&author=Tasaki%2CA's gross income?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18720533?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Nuclear%20factor%20kappa%20B%3A%20a%20marker%20of%20chemotherapy%20for%20human%20stage%20IV%20gastric%20carcinoma&journal=World%20J%20Gastroenterol&doi=10.3748%2Fwjg.14.4739&volume=14&pages=4739-4744&publication_year=2008&author=Long%2CYM&author=Ye%2CS&author=Rong%2CJ generate?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9918209?
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DyaK1MXhtVShtLY%3D pull in?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=The%20nuclear%20factor-kappa%20B%20RelA%20transcription%20factor%20is%20constitutively%20activated%20in%20human%20pancreatic%20adenocarcinoma%20cells&journal=Clin%20Cancer%20Res&volume=5&pages=119-127&publication_year=1999&author=Wang%2CW&author=Abbruzzese%2CJL&author=Evans%2CDB
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12538487's earnings
- How much profit does https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BD3sXnt1Oruw%3D%3D make?
- How much does http://scholar.google.com/scholar_lookup?&title=Function%20of%20nuclear%20factor%20kappaB%20in%20pancreatic%20cancer%20metastasis&journal=Clin%20Cancer%20Res&volume=9&pages=346-354&publication_year=2003&author=Fujioka%2CS&author=Sclabas%2CGM&author=Schmidt%2CC bring in each month?
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10202930?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Control%20of%20inducible%20chemoresistance%3A%20enhanced%20anti-tumor%20therapy%20through%20increased%20apoptosis%20by%20inhibition%20of%20NF-kappaB&journal=Nat%20Med&doi=10.1038%2F10577&volume=5&pages=412-417&publication_year=1999&author=Wang%2CCY&author=Cusack%2CJC&author=Liu%2CR
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11996883?
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BD38XjsVSks7k%3D bring in each month?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Increase%20of%20the%20resistance%20of%20human%20cervical%20carcinoma%20cells%20to%20cisplatin%20by%20inhibition%20of%20the%20MEK%20to%20ERK%20signaling%20pathway%20partly%20via%20enhancement%20of%20anticancer%20drug-induced%20NF%20kappa%20B%20activation&journal=Biochem%20Pharmacol&doi=10.1016%2FS0006-2952%2802%2900908-5&volume=63&pages=1423-1430&publication_year=2002&author=Yeh%2CPY&author=Chuang%2CSE&author=Yeh%2CKH generate?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12584750 generate?
- How much revenue does https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BD3sXisVejt7c%3D bring in?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Disulfiram-mediated%20inhibition%20of%20NF-kappaB%20activity%20enhances%20cytotoxicity%20of%205-fluorouracil%20in%20human%20colorectal%20cancer%20cell%20lines&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.10972&volume=104&pages=504-511&publication_year=2003&author=Wang%2CW&author=McLeod%2CHL&author=Cassidy%2CJ?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12761494's earnings
- What's the financial gain of https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BD3sXjvFaksLw%3D?
- http://scholar.google.com/scholar_lookup?&title=Role%20of%20NF-kappaB%20and%20Akt%2FPI3%C2%A0K%20in%20the%20resistance%20of%20pancreatic%20carcinoma%20cell%20lines%20against%20gemcitabine-induced%20cell%20death&journal=Oncogene&doi=10.1038%2Fsj.onc.1206390&volume=22&pages=3243-3251&publication_year=2003&author=Arlt%2CA&author=Gehrz%2CA&author=M%C3%BCerk%C3%B6ster%2CS's total income per month
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11410792
- How profitable is https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BD3MXlt1egsb8%3D?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Proteasome%20inhibitor%201%20enhances%20paclitaxel-induced%20apoptosis%20in%20human%20lung%20adenocarcinoma%20cell%20line&journal=Oncol%20Rep&volume=8&pages=825-829&publication_year=2001&author=Oyaizu%2CH&author=Adachi%2CY&author=Okumura%2CT
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6271224
- How much money does https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DyaL38XjtVKjsg%3D%3D make?
- Earnings of http://scholar.google.com/scholar_lookup?&title=New%20synthetic%20inhibitors%20of%20C1r%2C%20C1%20esterase%2C%20thrombin%2C%20plasmin%2C%20kallikrein%20and%20trypsin&journal=Biochim%20Biophys%20Acta&doi=10.1016%2F0005-2744%2881%2990023-1&volume=661&pages=342-345&publication_year=1981&author=Fujii%2CS&author=Hitomi%2CY
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6482087 generate monthly?
- What's the total monthly financial gain of https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DyaL2cXkvVemtb0%3D?
- Get to know http://scholar.google.com/scholar_lookup?&title=Pharmacological%20studies%20of%20FUT-175%2C%20nafamstat%20mesilate.%20I.%20Inhibition%20of%20protease%20activity%20in%20in%20vitro%20and%20in%20vivo%20experiments&journal=Jpn%20J%20Pharmacol&doi=10.1254%2Fjjp.35.203&volume=35&pages=203-227&publication_year=1984&author=Aoyama%2CT&author=Ino%2CY&author=Ozeki%2CM's earnings
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2427760's total income per month
- Discover the revenue of https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DyaL28XktlGns7c%3D
- Profit of http://scholar.google.com/scholar_lookup?&title=Pharmacological%20studies%20of%20FUT-175%2C%20nafamostat%20mesilate.%20V.%20Effects%20on%20the%20pancreatic%20enzymes%20and%20experimental%20acute%20pancreatitis%20in%20rats&journal=Jpn%20J%20Pharmacol&doi=10.1254%2Fjjp.41.155&volume=41&pages=155-162&publication_year=1986&author=Iwaki%2CM&author=Ino%2CY&author=Motoyoshi%2CA
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6667905's financial summary
- How much revenue does https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:STN:280:DyaL2c7jtlGjsQ%3D%3D produce monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Effects%20of%20FUT-175%2C%20a%20new%20synthetic%20protease%20inhibitor%20on%20endotoxin-induced%20disseminated%20intravascular%20coagulation%20in%20rats&journal=Haemostasis&volume=13&pages=374-378&publication_year=1983&author=Yoshikawa%2CT&author=Murakami%2CM&author=Furukawa%2CY earn?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1666354 pull in?
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:STN:280:DyaK383gtV2gtA%3D%3D rake in every month?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Nafamostat%20mesylate%20as%20anticoagulant%20in%20continuous%20hemofiltration%20and%20continuous%20hemodiafiltration&journal=Contrib%20Nephrol&volume=93&pages=215-217&publication_year=1991&author=Ohtake%2CY&author=Hirasawa%2CH&author=Sugai%2CT?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17410536?
- Income figures for https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BD2sXmtV2qsL0%3D
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20synthetic%20serine%20protease%20inhibitor%20%28FUT-175%29-mediated%20cell%20death&journal=Cancer&doi=10.1002%2Fcncr.22658&volume=109&pages=2142-2153&publication_year=2007&author=Uwagawa%2CT&author=Li%2CZ&author=Chang%2CZ?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20811662 rake in every month?
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BC3cXht1GrtL3E earn?
- See how much http://scholar.google.com/scholar_lookup?&title=Anti-tumor%20effect%20by%20inhibition%20of%20NF-kappaB%20activation%20using%20nafamostat%20mesilate%20for%20pancreatic%20cancer%20in%20a%20mouse%20model&journal=Oncol%20Rep&doi=10.3892%2For.2010.843&volume=24&pages=843-850&publication_year=2010&author=Furukawa%2CK&author=Iida%2CT&author=Shiba%2CH makes per month
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19661331 earning monthly?
- What's the financial intake of https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BD1MXhtVeku7rL?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Combination%20chemotherapy%20of%20nafamostat%20mesilate%20with%20gemcitabine%20for%20pancreatic%20cancer%20targeting%20NF-kappaB%20activation&journal=Anticancer%20Res&volume=29&pages=3173-3178&publication_year=2009&author=Uwagawa%2CT&author=Chiao%2CPJ&author=Gocho%2CT making per month?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18836085's financial summary
- How much income is https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:STN:280:DC%2BD1M7jtlWmug%3D%3D earning monthly?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=A%20phase%20I%20study%20of%20full-dose%20gemcitabine%20and%20regional%20arterial%20infusion%20of%20nafamostat%20mesilate%20for%20advanced%20pancreatic%20cancer&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdn640&volume=20&pages=239-243&publication_year=2009&author=Uwagawa%2CT&author=Misawa%2CT&author=Sakamoto%2CT?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Phase%20II%20study%20of%20gemcitabine%20in%20combination%20with%20regional%20arterial%20infusion%20of%20nafamostat%20mesilate%20for%20advanced%20pancreatic%20cancer&journal=Am%20J%20Clin%20Oncol&doi=10.1097%2FCOC.0b013e31823a53b2&publication_year=2011&author=Uwagawa%2CT&author=Misawa%2CT&author=Tsutsui%2CN
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21343836 making per month?
- How much money does https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BC3MXksFGqsbY%3D generate?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Combination%20paclitaxel%20and%20inhibitor%20of%20nuclear%20factor%20%CE%BAB%20activation%20improves%20therapeutic%20outcome%20for%20model%20mice%20with%20peritoneal%20dissemination%20of%20pancreatic%20cancer&journal=Pancreas&doi=10.1097%2FMPA.0b013e31820b9257&volume=40&pages=600-607&publication_year=2011&author=Fujiwara%2CY&author=Furukawa%2CK&author=Shimada%2CY?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18358228
- Explore the financials of https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BD1cXlsFCmt7s%3D
- http://scholar.google.com/scholar_lookup?&title=A%20protocol%20for%20immunoaffinity%20separation%20of%20the%20accumulated%20ubiquitin-protein%20conjugates%20solubilized%20with%20sodium%20dodecyl%20sulfate&journal=Anal%20Biochem&doi=10.1016%2Fj.ab.2008.02.031&volume=377&pages=77-82&publication_year=2008&author=Shimada%2CY&author=Fukuda%2CT&author=Aoki%2CK's financial summary
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6116707 earn?
- Monthly income for https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DyaL3MXlvValtb0%3D
- Profit of http://scholar.google.com/scholar_lookup?&title=Taxol-induced%20polymerization%20of%20purified%20tubulin%3A%20mechanism%20of%20action&journal=J%20Biol%20Chem&volume=256&pages=10435-10441&publication_year=1981&author=Kumar%2CN
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6113842
- https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DyaL3MXktFyjs78%3D's revenue stream
- http://scholar.google.com/scholar_lookup?&title=Taxol%20assembles%20tubulin%20in%20the%20absence%20of%20exogenous%20guanosine%205%E2%80%B2-triphosphate%20or%20microtubule-associated%20proteins&journal=Biochemistry&doi=10.1021%2Fbi00514a041&volume=20&pages=3247-3252&publication_year=1981&author=Schiff%2CPB&author=Horwitz%2CSB's total income per month
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2898289?
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DyaL1cXkvVGrurc%3D gross monthly?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Microtubule%20changes%20and%20cytotoxicity%20in%20leukemic%20cell%20lines%20treated%20with%20Taxol&journal=Cancer%20Res&volume=48&pages=4093-4100&publication_year=1988&author=Rowinsky%2CEK&author=Donehower%2CRC&author=Jones%2CRJ?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=423966 making per month?
- What's the income generated by https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DyaE1MXkvVCitrY%3D each month?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Promotion%20of%20microtubule%20assembly%20in%20vitro%20by%20Taxol&journal=Nature&doi=10.1038%2F277665a0&volume=277&pages=665-667&publication_year=1979&author=Schiff%2CPB&author=Faut%2CJ&author=Horwitz%2CSB?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1350385 each month?
- What's the income of https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DyaK38XktVSjtLw%3D?
- How much does http://scholar.google.com/scholar_lookup?&title=Mechanism%20of%20action%20taxol&journal=Trends%20Pharmacol%20Sci&doi=10.1016%2F0165-6147%2892%2990048-B&volume=13&pages=134-136&publication_year=1992&author=Horwitz%2CSB pull in?
- How much income does https://link.springer.com/doi/10.1007/978-1-4613-1247-5_4 have?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8849943 earns monthly
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:STN:280:DyaK2s%2Fgt1GqtA%3D%3D generate monthly?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Peritoneal-plasma%20barrier&journal=Cancer%20Treat%20Res&doi=10.1007%2F978-1-4613-1247-5_4&volume=82&pages=53-63&publication_year=1996&author=Jacquet%2CP&author=Sugarbaker%2CPH earns monthly
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7967989?
- Revenue of https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:STN:280:DyaK2M%2FlslGlsQ%3D%3D
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=The%20taxoids%3A%20paclitaxel%20and%20docetaxel&journal=Lancet&doi=10.1016%2FS0140-6736%2894%2990754-4&volume=344&pages=1267-1272&publication_year=1994&author=Gelmon%2CK?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3545463 produce monthly?
- What's https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:STN:280:DyaL2s7jtVygtg%3D%3D's gross income?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Intraperitoneal%20antineoplastic%20agents%20for%20tumors%20principally%20confined%20to%20the%20peritoneal%20cavity&journal=Cancer%20Treat%20Rev&doi=10.1016%2F0305-7372%2886%2990007-1&volume=13&pages=219-242&publication_year=1986&author=Markman%2CM?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8630921 bring in each month?
- https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DyaK28XlsV2guw%3D%3D's financial summary
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Paclitaxel-induced%20apoptosis%20in%20human%20gastric%20carcinoma%20cell%20lines&journal=Cancer&doi=10.1002%2F%28SICI%291097-0142%2819960101%2977%3A1%3C14%3A%3AAID-CNCR4%3E3.0.CO%3B2-N&volume=77&pages=14-18&publication_year=1996&author=Chang%2CYF&author=Li%2CLL&author=Wu%2CCW?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9733516
- https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DyaK1cXmtVWhurk%3D's total income per month
- How much does http://scholar.google.com/scholar_lookup?&title=NF-kappaB%20antiapoptosis%3A%20induction%20of%20TRAF1%20and%20TRAF2%20and%20c-IAP1%20and%20c-IAP2%20to%20suppress%20caspase-8%20activation&journal=Science&doi=10.1126%2Fscience.281.5383.1680&volume=281&pages=1680-1683&publication_year=1998&author=Wang%2CCY&author=Mayo%2CMW&author=Korneluk%2CRG make?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15569997
- What are the earnings of https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BD2cXhtVanurzL?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20inhibitor%20of%20nuclear%20factor-kappaB%20phosphorylation%20increases%20the%20efficacy%20of%20paclitaxel%20in%20in%20vitro%20and%20in%20vivo%20ovarian%20cancer%20models&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-04-0958&volume=10&pages=7645-7654&publication_year=2004&author=Mabuchi%2CS&author=Ohmichi%2CM&author=Nishio%2CY?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16243823
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BD2MXhtFartbjM pull in?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Curcumin%20suppresses%20the%20paclitaxel-induced%20nuclear%20factor-kappaB%20pathway%20in%20breast%20cancer%20cells%20and%20inhibits%20lung%20metastasis%20of%20human%20breast%20cancer%20in%20nude%20mice&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-1192&volume=11&pages=7490-7498&publication_year=2005&author=Aggarwal%2CBB&author=Shishodia%2CS&author=Takada%2CY
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18798274 make?
- Get to know https://link.springer.com/article/10.1007/s10620-012-2311-4/articles/cas-redirect/1:CAS:528:DC%2BD1cXhtlyru7nJ's earnings
- http://scholar.google.com/scholar_lookup?&title=Intraperitoneal%20administration%20of%20a%20small%20interfering%20RNA%20targeting%20nuclear%20factor-kappa%20B%20with%20paclitaxel%20successfully%20prolongs%20the%20survival%20of%20xenograft%20model%20mice%20with%20peritoneal%20metastasis%20of%20gastric%20cancer&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.23867&volume=123&pages=2696-2701&publication_year=2008&author=Inoue%2CM&author=Matsumoto%2CS&author=Saito%2CH's revenue stream
- https://citation-needed.springer.com/v2/references/10.1007/s10620-012-2311-4?format=refman&flavour=references's revenue stream
- https://link.springer.com/article/10.1007/s10620-012-2311-4/search?sortBy=newestFirst&dc.creator=Koichiro%20Haruki's revenue stream
- What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Koichiro%20Haruki?
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Koichiro%20Haruki%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- What's the financial gain of https://link.springer.com/article/10.1007/s10620-012-2311-4/search?sortBy=newestFirst&dc.creator=Hiroaki%20Shiba?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hiroaki%20Shiba gross monthly?
- What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hiroaki%20Shiba%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What is the earnings of https://link.springer.com/article/10.1007/s10620-012-2311-4/search?sortBy=newestFirst&dc.creator=Yuki%20Fujiwara?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuki%20Fujiwara produce monthly?
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuki%20Fujiwara%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- What are the total earnings of https://link.springer.com/article/10.1007/s10620-012-2311-4/search?sortBy=newestFirst&dc.creator=Kenei%20Furukawa?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kenei%20Furukawa's total income per month
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kenei%20Furukawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/search?sortBy=newestFirst&dc.creator=Ryota%20Iwase net monthly?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ryota%20Iwase's revenue stream
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ryota%20Iwase%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/search?sortBy=newestFirst&dc.creator=Tadashi%20Uwagawa pull in monthly?
- What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tadashi%20Uwagawa?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tadashi%20Uwagawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- Explore the financials of https://link.springer.com/article/10.1007/s10620-012-2311-4/search?sortBy=newestFirst&dc.creator=Takeyuki%20Misawa
- What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Takeyuki%20Misawa's gross income?
- What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Takeyuki%20Misawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial gain of https://link.springer.com/article/10.1007/s10620-012-2311-4/search?sortBy=newestFirst&dc.creator=Toya%20Ohashi?
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Toya%20Ohashi?
- What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Toya%20Ohashi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the revenue for https://link.springer.com/article/10.1007/s10620-012-2311-4/search?sortBy=newestFirst&dc.creator=Katsuhiko%20Yanaga?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Katsuhiko%20Yanaga?
- What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Katsuhiko%20Yanaga%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://link.springer.com/article/10.1007/s10620-012-2311-4/mailto:[email protected] rake in every month?
- How much money does https://s100.copyright.com/AppDispatchServlet?title=Inhibition%20of%20Nuclear%20Factor-%CE%BAB%20Enhances%20the%20Antitumor%20Effect%20of%20Paclitaxel%20Against%20Gastric%20Cancer%20with%20Peritoneal%20Dissemination%20in%20Mice&author=Koichiro%20Haruki%20et%20al&contentID=10.1007%2Fs10620-012-2311-4©right=Springer%20Science%2BBusiness%20Media%2C%20LLC&publication=0163-2116&publicationDate=2012-07-18&publisherName=SpringerNature&orderBeanReset=true generate?
- How much money does https://citation-needed.springer.com/v2/references/10.1007/s10620-012-2311-4?format=refman&flavour=citation generate?
- What's the income of https://link.springer.com/article/10.1007/s10620-012-2311-4/search?query=Nafamostat%20mesilate&facet-discipline="Medicine%20%26%20Public%20Health"?
- What's https://link.springer.com/article/10.1007/s10620-012-2311-4/search?query=Paclitaxel&facet-discipline="Medicine%20%26%20Public%20Health"'s gross income?
- Explore the financials of https://link.springer.com/article/10.1007/s10620-012-2311-4/search?query=Gastric%20cancer&facet-discipline="Medicine%20%26%20Public%20Health"
- How much cash flow does https://link.springer.com/article/10.1007/s10620-012-2311-4/search?query=Peritoneal%20dissemination&facet-discipline="Medicine%20%26%20Public%20Health" have monthly?
- https://link.springer.com/article/10.1007/s10620-012-2311-4/search?query=Intraperitoneal%20chemotherapy&facet-discipline="Medicine%20%26%20Public%20Health"'s revenue stream
- Learn how profitable https://link.springer.com/journals/a/1 is on a monthly basis
- How much revenue does https://link.springer.com/books/a/1 generate?
- See how much https://link.springer.com/journals makes per month
- How much does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral pull in monthly?
- Profit of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
- Revenue of https://www.springernature.com/gp/products
- https://www.springernature.com/gp/librarians's financial summary
- Revenue of https://www.springernature.com/gp/societies
- How much income is https://www.springernature.com/gp/partners earning monthly?
- What's the financial outcome of https://www.springer.com/?
- How profitable is https://www.nature.com/?
- Monthly income for https://www.biomedcentral.com/
- How much profit does https://www.palgrave.com/ generate?
- How much profit does https://www.apress.com/ make?
- What's the revenue for https://link.springer.com/brands/discover?
- How much does https://www.springernature.com/gp/legal/ccpa net monthly?
- How much money does https://www.springernature.com/gp/info/accessibility make?
- What's the income of https://link.springer.com/termsandconditions?
- How much does https://support.springernature.com/en/support/home net monthly?
- Find out how much https://link.springer.com/legal-notice earns monthly
- How much does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations make?
- How much does https://www.springernature.com/ earn?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
Emails and Hosting {✉️}
Mail Servers:
- mx.zoho.eu
- mx2.zoho.eu
- mx3.zoho.eu
Name Servers:
- josh.ns.cloudflare.com
- zita.ns.cloudflare.com
CDN Services {📦}
- Crossref